"The world's second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing world.
In a major change of strategy, the new head of GlaxoSmithKline, Andrew Witty, has told the Guardian he will slash prices on all medicines in the poorest countries, give back profits to be spent on hospitals and clinics and – most ground-breaking of all – share knowledge about potential drugs that are currently protected by patents."
Monday, February 16, 2009
Drug giant GlaxoSmithKline pledges cheap medicine for world's poor
Drug giant GlaxoSmithKline pledges cheap medicine for world's poor | Business | The Guardian:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment